Authors:
DATE J
FELDTRASMUSSEN U
BLICHERTTOFT M
HEGEDUS L
GRAVERSEN HP
Citation: J. Date et al., LONG-TERM OBSERVATION OF SERUM THYROGLOBULIN AFTER RESECTION OF NONTOXIC GOITER AND RELATION TO ULTRASONOGRAPHICALLY DEMONSTRATED RELAPSE, World journal of surgery, 20(3), 1996, pp. 351-357
Authors:
HEGEDUS L
NOSZTICZIUS Z
PAPP A
SCHUBERT AP
WITTMANN M
Citation: L. Hegedus et al., POLARIZATION PHENOMENA IN HYDROGEL MEMBRANES - EXPERIMENTAL REALIZATION OF AN ELECTROLYTE DIODE, ACH, models in chemistry, 132(1-2), 1995, pp. 207-224
Authors:
NYGAARD B
HEGEDUS L
GERVIL M
HJALGRIM H
HANSEN BM
SOEJENSEN P
HANSEN JM
Citation: B. Nygaard et al., INFLUENCE OF COMPENSATED RADIOIODINE THERAPY ON THYROID VOLUME AND INCIDENCE OF HYPOTHYROIDISM IN GRAVES-DISEASE, Journal of internal medicine, 238(6), 1995, pp. 491-497
Authors:
KLAUSEN IC
HEGEDUS L
HANSEN PS
NIELSEN FE
GERDES LU
FAERGEMAN O
Citation: Ic. Klausen et al., APOLIPOPROTEIN(A) PHENOTYPES AND LIPOPROTEIN(A) CONCENTRATIONS IN PATIENTS WITH HYPERTHYROIDISM, Journal of molecular medicine, 73(1), 1995, pp. 41-46
Citation: L. Hegedus et J. Faber, CALCULATION OF THE IDEAL DOSE OF RADIOIODINE FOR TREATMENT OF THYROID-DISEASE, European journal of endocrinology, 132(5), 1995, pp. 544-545
Authors:
BOGNER U
HEGEDUS L
HANSEN JM
FINKE R
SCHLEUSENER H
Citation: U. Bogner et al., THYROID CYTOTOXIC ANTIBODIES IN ATROPHIC AND GOITROUS AUTOIMMUNE-THYROIDITIS, European journal of endocrinology, 132(1), 1995, pp. 69-74
Authors:
JARLOV AE
HEGEDUS L
KRISTENSEN LO
NYGAARD B
HANSEN JM
Citation: Ae. Jarlov et al., IS CALCULATION OF THE DOSE IN RADIOIODINE THERAPY OF HYPERTHYROIDISM WORTH WHILE, Clinical endocrinology, 43(3), 1995, pp. 325-329
Authors:
NYGAARD B
FABER J
VEJE A
HEGEDUS L
HANSEN JM
Citation: B. Nygaard et al., APPEARANCE OF GRAVES-LIKE DISEASE AFTER RADIOIODINE THERAPY FOR TOXICAS WELL AS NONTOXIC MULTINODULAR GOITER, Clinical endocrinology, 43(1), 1995, pp. 129-130
Authors:
ASTHANA S
GREIG NH
HEGEDUS L
HOLLOWAY HH
RAFFAELE KC
SCHAPIRO MB
SONCRANT TT
Citation: S. Asthana et al., CLINICAL PHARMACOKINETICS OF PHYSOSTIGMINE IN PATIENTS WITH ALZHEIMERS-DISEASE, Clinical pharmacology and therapeutics, 58(3), 1995, pp. 299-309
Authors:
NYGAARD B
JARLOV AE
HEGEDUS L
SCHAADT B
KRISTENSEN LO
HANSEN JM
Citation: B. Nygaard et al., LONG-TERM FOLLOW-UP OF THYROID SCINTIGRAPHIES AFTER I-131 THERAPY OF SOLITARY AUTONOMOUS THYROID-NODULES, Thyroid, 4(2), 1994, pp. 167-171
Citation: B. Nygaard et al., ACUTE CHANGES IN THYROID VOLUME AND FUNCTION FOLLOWING I-131 THERAPY OF MULTINODULAR GOITER, Clinical endocrinology, 41(6), 1994, pp. 715-718
Citation: L. Hegedus, LOADING ARRANGEMENT AND STRUCTURE, AS ONE SYSTEM TEMPORARY INSTABILITY OF ELEMENTS AND STRUCTURE, Thin-walled structures, 20(1-4), 1994, pp. 61-71
Citation: T. Patonay et al., ALPHA-HALOALKYL HALOFORMATES AND RELATED-COMPOUNDS .2. SYNTHESIS OF DICHLOROMETHYL CARBONATES AND THEIR TRANSFORMATION TO CARBAMATES, Synthetic communications, 24(17), 1994, pp. 2507-2513
Authors:
RUF J
FELDTRASMUSSEN U
HEGEDUS L
FERRAND M
CARAYON P
Citation: J. Ruf et al., BISPECIFIC THYROGLOBULIN AND THYROPEROXIDASE AUTOANTIBODIES IN PATIENTS WITH VARIOUS THYROID AND AUTOIMMUNE-DISEASES, The Journal of clinical endocrinology and metabolism, 79(5), 1994, pp. 1404-1409
Citation: M. Barany et al., DISSOCIATION OF RELAXATION AND MYOSIN LIGHT-CHAIN DEPHOSPHORYLATION IN SMOOTH-MUSCLE, Biophysical journal, 66(2), 1994, pp. 10000139-10000139
Citation: S. Karstrup et al., ULTRASONICALLY GUIDED CHEMICAL PARATHYROIDECTOMY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM - A FOLLOW-UP-STUDY, Clinical endocrinology, 38(5), 1993, pp. 523-530
Authors:
JARLOV AE
NYGARD B
HEGEDUS L
KARSTRUP S
HANSEN JM
Citation: Ae. Jarlov et al., OBSERVER VARIATION IN ULTRASOUND ASSESSMENT OF THE THYROID-GLAND, British journal of radiology, 66(787), 1993, pp. 625-627